INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Inhibrx Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$89.79−0.04 (-0.04%)
Close on Oct 19, 2026
- Market cap
- $1.41B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Inhibrx Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 28, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 8, 2026 | Sep 8, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2026 | Jul 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 23, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 21, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 19, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 16, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 23, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2025 | Aug 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | May 28, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 16, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Apr 1, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 17, 2025 | Mar 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 21, 2025 | Jan 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2024 | Nov 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 14, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2024 | Nov 4, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2024 | Jun 17, 2024 | SEC EDGAR |
| Current report | 8-K | May 30, 2024 | May 30, 2024 | SEC EDGAR |
| Current report | 8-K | May 29, 2024 | May 30, 2024 | SEC EDGAR |
| Current report | 8-K | May 24, 2024 | May 24, 2024 | SEC EDGAR |
| Current report | 8-K | May 24, 2024 | May 24, 2024 | SEC EDGAR |